Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
obesity drugs
Content Channel
CordenPharma to snap up peptide API maker with US, China sites
Amid a nearly $1 billion GLP-1 manufacturing expansion that began in 2024, CMDO CordenPharma is doubling down on its peptide capacity ambitions.
Fraiser Kansteiner
May 27, 2026 10:39am
The Oral GLP-1 Tracker: Wegovy pill numbers show its appeal
May 22, 2026 10:36am
Trump bought stock in drugmaker as admin boosted its obesity drugs
May 19, 2026 8:47am
Novo, Lilly unveil new obesity data as GLP-1 rivalry grows
May 13, 2026 11:18am
Novo's Wegovy pill debuts with $355M in Q1
May 6, 2026 11:21am
Generic versions of Novo's semaglutide launch today in India
Mar 20, 2026 11:27am
